Anzeige
Meldung des Tages: Breaking News: TeaRx™ erobert Großbritannien im Sturm?!

Becton Dickinson Aktie News

Aktie
WKN:  857675 ISIN:  US0758871091 US-Symbol:  BDX Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
185,39 $
+2,92 $
+1,60%
157,36 € 20.02.26
Depot/Watchlist
Marktkapitalisierung *
47,80 Mrd. €
Streubesitz
5,15%
KGV
31,83
Dividende
3,34 $
Dividendenrendite
2,15%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 11,48: MN32ZA
Werbung

Becton Dickinson News

19.02.26 - PR Newswire
Lanesha Minnix Named General Counsel for BD
Lanesha Minnix Named General Counsel for BD PR Newswire
10.02.26 - PR Newswire
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR Newswire
09.02.26 - PR Newswire
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire
09.02.26 - PR Newswire
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation PR Newswire
09.02.26 - PR Newswire
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire
09.02.26 - PR Newswire
BD Reports First Quarter Fiscal 2026 Financial Results
BD Reports First Quarter Fiscal 2026 Financial Results PR Newswire
29.01.26 - PR Newswire
BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care
BD and Envetec Demonstrate Closed-​Loop Recycling Solution for Laboratory Plastics in Health Care PR Newswire
27.01.26 - PR Newswire
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 PR Newswire
27.01.26 - PR Newswire
BD to Announce Financial Results for its First Quarter of Fiscal 2026
BD to Announce Financial Results for its First Quarter of Fiscal 2026 PR Newswire
27.01.26 - PR Newswire
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business PR Newswire
27.01.26 - PR Newswire
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business PR Newswire
27.01.26 - PR Newswire
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business PR Newswire
23.01.26 - PR Newswire
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
BD Helps Scientists Advance Immunology and Cancer Research with AI-​Powered Insights and Automation PR Newswire
21.01.26 - PR Newswire
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market PR Newswire
15.01.26 - PR Newswire
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System PR Newswire
14.01.26 - PR Newswire
BD Names Shawn Bevec as Senior Vice President of Investor Relations
BD Names Shawn Bevec as Senior Vice President of Investor Relations PR Newswire
13.01.26 - PR Newswire
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs PR Newswire
12.01.26 - PR Newswire
BD To Host Virtual 2026 Annual Meeting of Shareholders
BD To Host Virtual 2026 Annual Meeting of Shareholders PR Newswire
07.01.26 - PR Newswire
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
Waters Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT PR Newswire
05.01.26 - PR Newswire
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial PR Newswire

Newssuche

Videos

newspaper
18.02.26 -2,76%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
DiagnosTear Technologies Inc
0,268 €
+5,51%
DiagnosTear Technologies Inc Chart
TeaRx™ erobert Großbritannien im Sturm?!
Mehr zur Aktie »